Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chongqing Xieran Pharmaceutical is a comprehensive pharmaceutical enterprise based in Chongqing, China, that specializes in the research, development, and manufacturing of Traditional Chinese Medicine (TCM) and chemical drugs. The company is widely recognized for its Wansheng brand, which carries a legacy of over 300 years in Chinese medicine. Xieran's product portfolio is particularly strong in the anorectal, orthopedic, pediatric, and gynecological therapeutic areas, with its Musk Hemorrhoid Ointment serving as a flagship commercial success. The firm operates modern, GMP-certified production facilities capable of handling diverse dosage forms including ointments, tablets, and capsules. As a National High-tech Enterprise, Xieran continues to invest in the modernization of TCM and the development of high-quality generic chemical pharmaceuticals. The company maintains a robust domestic distribution network, consistently ranking among the top pharmaceutical industrial players in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chongqing Xieran Pharmaceutical.